Results 81 to 90 of about 54,247 (234)

Specific Anti Mumps Antibodies (IgG & IgM) in Cerebrospinal Fluid of Mumps Meningoencephalitic Children

open access: yesActa Medica Iranica, 2009
Mumps infection is endemic in Iran. Our objective was to evaluate the presence of anti mumps antibodies ( IgM & IgG) in cerebrospinal fluid in mumps meningoencephalitic children.
Samileh Noorbakhsh   +4 more
doaj  

Analysis of serum th1/th2 cytokine levels in patients with acute mumps infection

open access: yesJournal of Global Infectious Diseases, 2016
Background: The mumps virus is frequently the causative agent of parotitis. There has been no study on serum cytokine levels of acute mumps parotitis except for a few which document cytokine levels in cerebrospinal fluid of mumps meningitis.
Jeevan Malaiyan   +3 more
doaj   +1 more source

Ethical Considerations Regarding the Vaccination of Children—The Power Dynamics Between Doctors and Parents

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2414-2420, November 2026.
ABSTRACT While childhood vaccination programmes provide outstanding contributions to improving health, they can also pose challenges through the interactions between parents and healthcare. This paper focuses on the ethical dimensions of interactions between healthcare professionals and parents. Since the knowledge that professionals possess creates an
Mikael Sandlund   +2 more
wiley   +1 more source

Modelling Impact of Different Varicella Immunisation Strategies Upon Introduction in the Swedish National Programme

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2525-2532, November 2026.
ABSTRACT Aim Countries with varicella immunisation programmes have seen major reductions in disease burden. While two‐dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch‐up vaccination of older children to speed impact. This modelling study assessed three two‐dose schedules in the Swedish setting (1)
Gianpaolo Scalia Tomba   +6 more
wiley   +1 more source

Mumps-containing vaccine effectiveness during outbreaks in two schools in Guangdong, China, 2012

open access: yesWestern Pacific Surveillance and Response, 2012
Introduction: Mumps-containing vaccine was licensed in the 1990s in China with a single dose administered routinely to children aged 18-24 months since 2008.
Man Wang   +6 more
doaj   +1 more source

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2460-2465, November 2026.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson   +2 more
wiley   +1 more source

Health Economic Evaluation of Varicella Vaccination Within the Swedish National Vaccination Programme for Children

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2533-2544, November 2026.
ABSTRACT Aim To assess the cost‐effectiveness of including varicella vaccination in the Swedish national vaccination programme for children together with the added impact of catch‐up vaccination of susceptible older children. Methods An epidemiological transmission model was used to assess the cost‐effectiveness of a two‐dose national varicella ...
Frida Kasteng   +5 more
wiley   +1 more source

Against the clock: Effect of late detection of a mumps outbreak in the Western North Region of Ghana, 2022 [PDF]

open access: yes
Background: Mumps is an acute viral illness caused by the Mumps Virus (MuV) that spreads through direct contact with infected individuals. While children typically experience a mild form of the disease, adults may suffer from more severe complications ...
Marion Okoh-Owusu   +13 more
core   +1 more source

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2603-2615, November 2026.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz   +17 more
wiley   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2370-2379, November 2026.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Home - About - Disclaimer - Privacy